Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05370599 · ClinicalTrials.gov registry record · Phase 2
Hypertension in Young Adults Trial
A Phase 2 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT05370599 is a Phase 2 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 36 participants.
The verdict
NCT05370599, a Phase 2 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a pilot randomized controlled trial which will test the effect of 3 different anti-hypertensive agents and 3 different strategies of engaging young adults in home blood pressure monitoring on blood pressure control, with secondary outcomes focused on quality of life and adverse events.
Interventions
- DRUG Anti-hypertensive agent: amlodipine
- DRUG Anti-hypertensive agent: Chlorthalidone
- DRUG Anti-hypertensive agent: Losartan
- DEVICE Home BP monitoring with cuffed device
- DEVICE Home BP monitoring with cuffed device + BP patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2026-01-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05370599
The ClinicalTrials.gov registry entry for NCT05370599 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Anti-hypertensive agent: amlodipine is the first listed.
NCT05370599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05370599 about?
NCT05370599 is a clinical study titled "Hypertension in Young Adults Trial". This is a pilot randomized controlled trial which will test the effect of 3 different anti-hypertensive agents and 3 different strategies of engaging young adults in home blood pressure monitoring on blood pressure control, with secondary outcomes focused on quality of life and adverse events.
What is the current status of trial NCT05370599?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2022-04-15. Estimated completion is 2026-01-07.
What interventions are being tested in trial NCT05370599?
The interventions under investigation include: Anti-hypertensive agent: amlodipine (DRUG), Anti-hypertensive agent: Chlorthalidone (DRUG), Anti-hypertensive agent: Losartan (DRUG), Home BP monitoring with cuffed device (DEVICE), Home BP monitoring with cuffed device + BP patch (DEVICE).
Who is sponsoring clinical trial NCT05370599?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.